RARA CRAFT DATABASE for FDA Medical Devices
510(k)K191708

FDA DEVICE FACTS

Origin Stem, Evolve Stem, Aria Hip Stem, Remedy Stem, CoCr Femoral Head

Signature Orthopaedics Pty, Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEAugust 14, 2020PRODUCT CODELPH

Indications for use

Components of the Signature Orthopaedics hip replacement range are intended to replace a hip joint where bone stock is sufficient to support the implant. When a surgeon has selected prosthetic replacement as the preferred treaent, the devices are indicated for:

• Non-inflammatory degenerative joint disease including osteoarthritis or avascular necrosis

• Inflammatory joint disease including rheumatoid arthritis

• Correction of functional deformity including congenital hip dysplasia

• Traumatic injury involving the hip joint including traumatic arthritis or femoral head or neck fracture

• Failed previous hip surgery including internal fixation or joint fusion, reconstruction, hemiarthroplasty, surface replacement, or total replacement Signature Orthopaedics Pty Ltd Signature Orthopaedics’ Origin, Aria, Remedy, TSI and Pegasus femoral stems and Logical acetabular cups are intended for cementless fixation only. Signature Orthopaedics’ Evolve, Cemented TSI (both CoCr and HNSS variants) and Cemented Origin femoral stems are intended for cemented fixation only. Signature Orthopaedics' constrained liner components are indicated particularly for patients at high risk of hip dislocation due to a history of prior dislocation, bone loss, joint or soft tissue laxity, neuromuscular disease or intraoperative instability. Signature Orthopaedics’ Evolve UniPolar Head and BiPolar Head are intended for hemi-hip arthroplasty only, where the natural acetabulum does not require replacement. The Evolve UniPolar Head and BiPolar Head are indicated for bone fractures or pathologies involving only the femoral head/neck and/or proximal femur, such as:

• Acute femoral head or neck fracture

• Fracture dislocation of the hip

• Avascular necrosis of the femoral head

• Non-union of femoral neck fractures

• Certain high subcapital and femoral neck fractures in the elderly

• Degenerative arthritis involving only the femoral head Performance Testing: The following non-clinical testings were evaluated as part of the engineering evaluations:

• Ceramic Head Testings per ISO 7206-10

• Ceramic Head Fatigue Burst Testing and Rotational Stability per Ceramtec Protocol

• Range of Motion per ISO 21535

• Rim Impingement per ASTM-F2582-14

• Stem Body Fatigue per ISO 7206-4

• Stem Neck Fatigue per ISO 7206-6

• Articulating Surface Wear per ISO 14242-1

• Head – Constrained Liner Assembly per Custom Protocol

• Head – Constrained Liner Disassembly per ISO 7206-10

• Head Pull Out per ISO 7206-10

• Fretting Corrosion Testing per ASTM-F1875

• Head Pull Out from BiPolar

• Femoral Head – Constrained Liner Lever-Out Disassembly The engineering evaluations concluded that the performance of the subject devices will remain at least equivalent to the predicate devices when used in combinations as per the expanded compatibility.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 24, 2026